Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML-Reference-Cited by-同舟云学术

Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML

Published:2008-12 Issue:12 Volume:32 Page:1830-1836
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Walker Alison R.,Komrokji Rami S.,Ifthikharuddin Jainulabdeen,Messina Patti,Mulford Deborah,Becker Michael,Friedberg Jonathan,Oliva Jamie,Phillips Gordon,Liesveld Jane L.,Abboud Camille

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission;Cassileth;N Engl J Med,1998

2. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia;Wiernik;Blood,1992

3. Acute myeloid leukemia;Lowenberg;N Engl J Med,1999

4. Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia;Robak;Leuk Lymphoma,2000

5. In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential;Chow;Leuk Lymphoma,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying key genes and functionally enriched pathways in acute myeloid leukemia by weighted gene co-expression network analysis;Journal of Applied Genetics;2024-07-09

2. The role of cladribine in acute myeloid leukemia: an old drug up to new tricks;Leukemia & Lymphoma;2019-11-22

3. Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia;Acta Haematologica;2018-12-05

4. Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?;Journal of Cancer Research and Clinical Oncology;2017-06-17

5. Revisiting the role of cladribine in acute myeloid leukemia: An improvement on past accomplishments or more old news?;American Journal of Hematology;2014-10-25